DRKS00029350招募中未知
EVERAGING INFLAMMATION FOR PRECISION MEDICINE IN DEPRESSION - ENFORCE
Goethe Universität Frankfurt0 个研究点目标入组 530 人开始时间: 2022年6月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 530
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 75 Years(—)
- 性别
- All
入选标准
- •Patients with depression:
- •Age: between 18 and 75 years
- •Presence of depressive disorder without psychotic symptoms (according to ICD 10: F32.0, F32.1, F32.2, F32.3, F33.2, F33.3) or bipolar affective disorder with depressive episode (ICD: F31.3, F31.4)
- •Capacity to consent
- •Patients with MS:
- •Inclusion criteria for patients* with MS:
- •o Age between 18 and 75
- •o Capacity to consent
- •o If applicable, the last cortisone treatment has taken place at least 7 days ago.
- •Controls:Inclusion criteria for healthy controls:
- •Age: between 18 and 75 years
- •Capacity to consent
排除标准
- •Exclusion criteria for patients with depression:
- •Presence of severe neurological disease, such as multiple sclerosis. (adjusted epilepsy is allowed)
- •Presence of an acute infection (pneumonia, urinary tract infection, sepsis)
- •Clearly organic or substance-induced cause of depression
- •Pregnancy and lactation
- •Psychiatric comorbidities are allowed as long as, in the opinion of the study physician there is no impairment at testing and will be documented
- •Other medical condition that, at the discretion of the physician, makes participation impossible.
- •Uncontrolled thyroid disease (thyroid disease must be anamnestically stable, i.e., no change in medication has been made in the last 28 days).
- •Exclusion criteria for patients with MS:
- •Acute infection (per history) or tumor.
- •Uncontrolled thyroid disease (thyroid disease must be anamnestically stable, i.e., no change in medication has been made in the last 28 days).
- •Exclusion criteria for healthy controls:
- •Presence of psychiatric illness or psychiatric illness in First-degree family members
- •Severe physical illness (tumor disease, chronic/acute infectious disease, neurodegenerative disease, rheumatological disease, severe inflammation, autoimmune diseases, neurological disease)
- •Pregnancy and lactation
- •Uncontrolled thyroid disease (thyroid disease must be anamnestically stable, i.e., no change in medication has been made in the last 28 days).
研究者
相似试验
进行中(未招募)
1 期
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) EradicatioDiffuse Intrinsic Pontine GliomaMedDRA version: 20.0Level: PTClassification code 10006143Term: Brain stem gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001929-32-ESGustave Roussy250
进行中(未招募)
1 期
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) EradicatioDiffuse Intrinsic Pontine Glioma and Diffuse midline glioma, K27M mutantMedDRA version: 20.0Level: PTClassification code 10006143Term: Brain stem gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001929-32-DKGustave Roussy409
进行中(未招募)
1 期
Biological, targeted medicine for Diffuse Intrinsic Pontine Glioma treatmentDiffuse Intrinsic Pontine GliomaMedDRA version: 20.0Level: PTClassification code 10006143Term: Brain stem gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001929-32-GBGustave Roussy250
招募中
2 期
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradicatiodiffuse intrinsic pontine glioma - brainstem glioma10029211NL-OMON49636Gustave Roussy15
进行中(未招募)
1 期
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) EradicatioDiffuse Intrinsic Pontine Glioma and Diffuse midline glioma, K27M mutantMedDRA version: 20.0Level: PTClassification code 10006143Term: Brain stem gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001929-32-SEGustave Roussy368
